Stay updated on Crizotinib in ROS1/MET Lung Cancer Clinical Trial

Sign up to get notified when there's something new on the Crizotinib in ROS1/MET Lung Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Crizotinib in ROS1/MET Lung Cancer Clinical Trial page

  1. Check
    2 days ago
    No Change Detected
  2. Check
    9 days ago
    Change Detected
    Summary
    The revision in the record history advances from v3.5.2 to v3.5.3, representing a minor update to the page's revision history.
    Difference
    0.1%
    Check dated 2026-04-30T16:36:42.000Z thumbnail image
  3. Check
    17 days ago
    No Change Detected
  4. Check
    24 days ago
    Change Detected
    Summary
    Added revision v3.5.2 to the Record History and removed revision v3.5.0.
    Difference
    0.1%
    Check dated 2026-04-16T10:12:31.000Z thumbnail image
  5. Check
    52 days ago
    Change Detected
    Summary
    Revision v3.5.0 was added and revision v3.4.3 was removed from the record history.
    Difference
    0.1%
    Check dated 2026-03-18T16:45:16.000Z thumbnail image
  6. Check
    60 days ago
    Change Detected
    Summary
    Revision history updated to add version v3.4.3 and remove version v3.4.2.
    Difference
    0.1%
    Check dated 2026-03-11T12:39:22.000Z thumbnail image
  7. Check
    88 days ago
    Change Detected
    Summary
    A new revision entry v3.4.2 was added to the record history. The funding status notice and the earlier revision (v3.4.1) were removed.
    Difference
    0.8%
    Check dated 2026-02-11T02:28:57.000Z thumbnail image
  8. Check
    95 days ago
    Change Detected
    Summary
    Added a site-wide Notice about government funding lapse and potential data delays. Updated the history with Revision: v3.4.1 and removed v3.4.0.
    Difference
    0.9%
    Check dated 2026-02-03T23:43:50.000Z thumbnail image

Stay in the know with updates to Crizotinib in ROS1/MET Lung Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Crizotinib in ROS1/MET Lung Cancer Clinical Trial page.